Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K. Tarrant, Taylor F. White, David A. Barrow, Charlene M. Santos, Roman G. Timoshchenko, Suzan K. Hanna, Ramesh K. Ramanathan, Craig R. Lee, Victoria L. Bae-Jump, Paola A. Gehrig, William C. Zamboni
Dive into the research topics of 'Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer'. Together they form a unique fingerprint.